Heron Therapeutics (HRTX) Return on Equity [ROE] (2011 - 2026)
Heron Therapeutics' Return on Equity [ROE] was -135.42% in Q2 2026, down 46.31 percentage points from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2022, Return on Equity [ROE] at Heron Therapeutics came in at -385.10%, down 245.12 percentage points from FY2021.
- Return on Equity [ROE] has now declined for three consecutive years, with a five-year change of -25.73 percentage points (FY2017 to FY2022).
- In earlier years, Return on Equity [ROE] was -139.98% in FY2021 (-69.25 pp), -70.72% in FY2020 (-17.78 pp), -52.95% in FY2019 (+19.12 pp) and -72.07% in FY2018 (+287.30 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn | -135.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -135.42% |
| Mar 31, 2026 | -89.11% |
| Dec 31, 2025 | -17.37% |
| Mar 31, 2023 | -13,513.58% |
| Dec 31, 2022 | -969.73% |
| Sep 30, 2022 | -58,218.49% |
| Jun 30, 2022 | -19,591.90% |
| Mar 31, 2022 | -450.39% |
| Dec 31, 2021 | -221.81% |
| Sep 30, 2021 | -161.74% |
| Jun 30, 2021 | -130.36% |
| Mar 31, 2021 | -105.17% |
| Dec 31, 2020 | -88.84% |
| Sep 30, 2020 | -75.26% |
| Jun 30, 2020 | -58.79% |
| Mar 31, 2020 | -51.66% |
| Dec 31, 2019 | -61.13% |
| Sep 30, 2019 | -68.60% |
| Jun 30, 2019 | -65.78% |
| Mar 31, 2019 | -56.03% |
API Access
Heron Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();